Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative.

Upadhyay VA, Geisler BP, Sun L, Uhl L, Kaufman RM, Stowell C, Makar RS, Bendapudi PK.

Br J Haematol. 2019 Aug;186(3):490-498. doi: 10.1111/bjh.15932. Epub 2019 May 26.

PMID:
31131442
2.

Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura.

Sun L, Mack J, Li A, Ryu J, Upadhyay VA, Uhl L, Kaufman RM, Stowell CP, Dzik WS, Makar RS, Bendapudi PK.

Blood Adv. 2019 May 14;3(9):1512-1518. doi: 10.1182/bloodadvances.2019031039.

3.

Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate.

Bendapudi PK, Robbins A, LeBoeuf N, Pozdnyakova O, Bhatt A, Duke F, Sells R, McQuiston J, Humrighouse B, Rouaisnel B, Colling M, Stephenson KE, Saavedra A, Losman JA.

Blood Adv. 2018 Nov 13;2(21):2917-2921. doi: 10.1182/bloodadvances.2018024430. No abstract available.

4.

Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation.

Bekendam RH, Iyu D, Passam F, Stopa JD, De Ceunynck K, Muse O, Bendapudi PK, Garnier CL, Gopal S, Crescence L, Chiu J, Furie B, Panicot-Dubois L, Hogg PJ, Dubois C, Flaumenhaft R.

J Thromb Haemost. 2018 Nov;16(11):2322-2335. doi: 10.1111/jth.14291. Epub 2018 Oct 12.

PMID:
30207066
5.

Perioperative management of a redo aortic root replacement in a patient with severe factor XI deficiency.

Fitzsimons MG, Leaf RK, Mack J, Bendapudi PK, Shen T, Cameron DE.

J Card Surg. 2018 Feb;33(2):86-89. doi: 10.1111/jocs.13526. Epub 2018 Feb 4.

PMID:
29399875
6.

Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis.

Colling ME, Bendapudi PK.

Transfus Med Rev. 2018 Apr;32(2):69-76. doi: 10.1016/j.tmrv.2017.10.001. Epub 2017 Oct 16. Review.

PMID:
29157918
7.

Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.

Li A, Bendapudi PK, Uhl L, Hamdan A, Kaufman RM, Makar RS.

Transfusion. 2017 Sep;57(9):2151-2158. doi: 10.1111/trf.14181. Epub 2017 Jun 20.

PMID:
28635017
8.

Clinical Scoring Systems in Thrombotic Microangiopathies.

Bendapudi PK, Upadhyay V, Sun L, Marques MB, Makar RS.

Semin Thromb Hemost. 2017 Jul;43(5):540-548. doi: 10.1055/s-0037-1603100. Epub 2017 Jun 8. Review. No abstract available.

PMID:
28597458
9.

Local and Systemic Changes Associated with Long-term, Percutaneous, Static Implantation of Titanium Alloys in Rhesus Macaques (Macaca mulatta).

Frydman GH, Marini RP, Bakthavatchalu V, Biddle KE, Muthupalani S, Vanderburg CR, Lai B, Bendapudi PK, Tompkins RG, Fox JG.

Comp Med. 2017 Mar 1;67(2):165-175.

10.

Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.

Bendapudi PK, Hurwitz S, Fry A, Marques MB, Waldo SW, Li A, Sun L, Upadhyay V, Hamdan A, Brunner AM, Gansner JM, Viswanathan S, Kaufman RM, Uhl L, Stowell CP, Dzik WH, Makar RS.

Lancet Haematol. 2017 Apr;4(4):e157-e164. doi: 10.1016/S2352-3026(17)30026-1. Epub 2017 Mar 2.

PMID:
28259520
11.

A substrate-driven allosteric switch that enhances PDI catalytic activity.

Bekendam RH, Bendapudi PK, Lin L, Nag PP, Pu J, Kennedy DR, Feldenzer A, Chiu J, Cook KM, Furie B, Huang M, Hogg PJ, Flaumenhaft R.

Nat Commun. 2016 Aug 30;7:12579. doi: 10.1038/ncomms12579.

12.

Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study.

Li A, Makar RS, Hurwitz S, Uhl L, Kaufman RM, Stowell CP, Dzik WS, Bendapudi PK.

Transfusion. 2016 Aug;56(8):2069-77. doi: 10.1111/trf.13654. Epub 2016 May 27.

PMID:
27232383
13.

Coagulation Biomarkers in Healthy Chinese-Origin Rhesus Macaques (Macaca mulatta).

Frydman GH, Bendapudi PK, Marini RP, Vanderburg CR, Tompkins RG, Fox JG.

J Am Assoc Lab Anim Sci. 2016;55(3):252-9.

14.

An Algorithmic Approach to the Diagnosis and Management of the Thrombotic Microangiopathies.

Bendapudi PK, Makar RS.

Am J Clin Pathol. 2016 Feb;145(2):152-4. doi: 10.1093/ajcp/aqw003. Epub 2016 Feb 9. No abstract available.

PMID:
26864515
15.

Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.

Bendapudi PK, Li A, Hamdan A, Uhl L, Kaufman R, Stowell C, Dzik W, Makar RS.

Br J Haematol. 2015 Dec;171(5):836-44. doi: 10.1111/bjh.13658. Epub 2015 Aug 28.

PMID:
26314936
16.

Survival and death signals can predict tumor response to therapy after oncogene inactivation.

Tran PT, Bendapudi PK, Lin HJ, Choi P, Koh S, Chen J, Horng G, Hughes NP, Schwartz LH, Miller VA, Kawashima T, Kitamura T, Paik D, Felsher DW.

Sci Transl Med. 2011 Oct 5;3(103):103ra99. doi: 10.1126/scitranslmed.3002018.

17.

(18)F and (18)FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivation.

Arvanitis C, Bendapudi PK, Tseng JR, Gambhir SS, Felsher DW.

Cancer Biol Ther. 2008 Dec;7(12):1947-51. Epub 2008 Dec 7.

18.

Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.

Tran PT, Fan AC, Bendapudi PK, Koh S, Komatsubara K, Chen J, Horng G, Bellovin DI, Giuriato S, Wang CS, Whitsett JA, Felsher DW.

PLoS One. 2008 May 7;3(5):e2125. doi: 10.1371/journal.pone.0002125.

19.

Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults.

Tran PT, Hara W, Su Z, Lin HJ, Bendapudi PK, Norton J, Teng N, King CR, Kapp DS.

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1146-53. doi: 10.1016/j.ijrobp.2008.02.012. Epub 2008 Apr 18.

PMID:
18394818
20.

Identifying critical signaling molecules for the treatment of cancer.

Arvanitis C, Bendapudi PK, Bachireddy P, Felsher DW.

Recent Results Cancer Res. 2007;172:5-24. Review. No abstract available.

PMID:
17607933
21.

Getting at MYC through RAS.

Bachireddy P, Bendapudi PK, Felsher DW.

Clin Cancer Res. 2005 Jun 15;11(12):4278-81. No abstract available.

Supplemental Content

Loading ...
Support Center